These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 17299888)

  • 1. Atypical antipsychotic agents ineffective for AD.
    Duke Med Health News; 2007 Jan; 13(1):8. PubMed ID: 17299888
    [No Abstract]   [Full Text] [Related]  

  • 2. The use of atypical antipsychotics after traumatic brain injury.
    Elovic EP; Jasey NN; Eisenberg ME
    J Head Trauma Rehabil; 2008; 23(2):132-5. PubMed ID: 18362767
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical symptom responses to atypical antipsychotic medications in Alzheimer's disease: phase 1 outcomes from the CATIE-AD effectiveness trial.
    Sultzer DL; Davis SM; Tariot PN; Dagerman KS; Lebowitz BD; Lyketsos CG; Rosenheck RA; Hsiao JK; Lieberman JA; Schneider LS;
    Am J Psychiatry; 2008 Jul; 165(7):844-54. PubMed ID: 18519523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atypical antipsychotics for the treatment of dementia-related behaviors: an update.
    Daiello LA
    Med Health R I; 2007 Jun; 90(6):191-4. PubMed ID: 17633594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Efficacy of atypical antipsychotics in patients with Alzheimer's dementia. CATIE-AD-Study (Clinical Antipsychotic Trials of Intervention Effectiveness Alzheimer's Disease)].
    Förstl H
    Internist (Berl); 2007 Jun; 48(6):642-4. PubMed ID: 17497111
    [No Abstract]   [Full Text] [Related]  

  • 6. Managing the acutely agitated and psychotic patient.
    Nordstrom K; Allen MH
    CNS Spectr; 2007 Oct; 12(10 Suppl 17):5-11. PubMed ID: 17934384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral risperidone, olanzapine and quetiapine versus haloperidol in psychotic agitation.
    Villari V; Rocca P; Fonzo V; Montemagni C; Pandullo P; Bogetto F
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):405-13. PubMed ID: 17900775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The outpatient use of atypical antipsychotics with Alzheimer's disease.
    Farver D
    S D Med; 2007 Mar; 60(3):113, 115. PubMed ID: 17455580
    [No Abstract]   [Full Text] [Related]  

  • 9. Antipsychotic drugs and schizophrenia.
    Essock SM; Covell NH; Jackson CT
    N Engl J Med; 2006 Jan; 354(3):298-300; author reply 298-300. PubMed ID: 16422020
    [No Abstract]   [Full Text] [Related]  

  • 10. Risperidone, olanzapine and quetiapine in the treatment of behavioral and psychological symptoms in patients with Alzheimer's disease: preliminary findings from a naturalistic, retrospective study.
    Rocca P; Marino F; Montemagni C; Perrone D; Bogetto F
    Psychiatry Clin Neurosci; 2007 Dec; 61(6):622-9. PubMed ID: 18081622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Focus on the metabolic consequences of long-term treatment with olanzapine, quetiapine and risperidone: are there differences?
    Meltzer HY
    Int J Neuropsychopharmacol; 2005 Jun; 8(2):153-6. PubMed ID: 15780147
    [No Abstract]   [Full Text] [Related]  

  • 12. Parkinsonism and akathisia with quetiapine: three case reports.
    Bharadwaj R; Grover S
    J Clin Psychiatry; 2008 Jul; 69(7):1189-91. PubMed ID: 18687022
    [No Abstract]   [Full Text] [Related]  

  • 13. The CATIE schizophrenia effectiveness trial.
    Delisi LE; Nasrallah HA
    Schizophr Res; 2005 Dec; 80(1):v-vi. PubMed ID: 16291292
    [No Abstract]   [Full Text] [Related]  

  • 14. Two new atypical antipsychotics: advantages and disadvantages.
    Lemon MD
    S D J Med; 1998 Aug; 51(8):285-6. PubMed ID: 9724957
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparison of risk of cerebrovascular events in an elderly VA population with dementia between antipsychotic and nonantipsychotic users.
    Barnett MJ; Wehring H; Perry PJ
    J Clin Psychopharmacol; 2007 Dec; 27(6):595-601. PubMed ID: 18004126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacy cost evaluation of risperidone, olanzapine, and quetiapine for the treatment of schizophrenia in acute care inpatient settings.
    Mladsi DM; Grogg AL; Irish WD; Lopez RB; Degen K; Swann A; Nimsch CT
    Curr Med Res Opin; 2004 Dec; 20(12):1883-93. PubMed ID: 15701206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atypical antipsychotic drugs and tardive dyskinesia: relevance of D2 receptor affinity.
    Bressan RA; Jones HM; Pilowsky LS
    J Psychopharmacol; 2004 Mar; 18(1):124-7. PubMed ID: 15107196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inpatient length of stay and atypical antipsychotic use among elderly patients with psychiatric disorders and Alzheimer's disease.
    Edell WS; Rupnow MF
    Manag Care Interface; 2003 May; 16(5):64-7. PubMed ID: 12789866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [New antipsychotic drugs].
    Weizer M; Levy A; Davidson M
    Harefuah; 1997 Jul; 133(1-2):57-60. PubMed ID: 9332062
    [No Abstract]   [Full Text] [Related]  

  • 20. The value of atypical antipsychotics in the treatment of schizophrenia.
    Jessen LM
    Manag Care; 2002 Jul; 11(7 Suppl):8-12; discussion 12-3. PubMed ID: 12181875
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.